[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_96":97},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","edh1esbv94q7f2awfcoqzcd3u","revision",3,"title","Welltower Inc. 提交最多166,666股普通股的注册文件","originalTitle","WELLTOWER INC. (0000766704) (Filer)","summary","Welltower Inc. 提交注册文件，拟在满足资格、服务及业绩条件后，向运营合作伙伴及获准指定人发行最多166,666股普通股，以结算“Welltower Fellowship Grant”项下的股权挂钩权益。","reason","source",{"_11":86,"_87":88,"_89":90,"_91":57,"_92":93,"_94":95},"links",{"_83":84,"_63":85},"publishedAt","2026-10-27T20:32:52.000Z","discoveredAt","2026-10-27T23:45:37.030Z","timelineAt","category","ai-products","tags",[81,82],"stockSymbols",[80],"score",20,"selected",false,"channel","news","story",{"_72":73,"_15":74},"x","readingMode","full","author","language","body",{"_76":-5,"_63":77,"_78":-5,"_79":40},"outline",[],"relatedStories",[75],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","f5jevrqxX5Vk",{"_72":73,"_15":74},"reportCount",2,"additionalSourceCount",0,"developmentCount","publicId","6ea75c15-8d10-4a7d-b825-df3147dbbf98","Welltower与Heron披露股权相关股份登记",{"_72":73,"_15":74},"zh","

Filed Pursuant to Rule 424(b)(5)

Registration No. 333-286204

PROSPECTUS SUPPLEMENT

(To prospectus dated March 28, 2025)

166,666 Shares

$\"welltower.jpg\"$

Common Stock

This prospectus supplement and the related prospectus relate to the possible issuance, from time to time, of up to 166,666 shares of our common stock to our operating partners and certain permitted designees pursuant to the vesting and settlement of equity-linked interests granted under the Welltower Fellowship Grant, established to honor the memory of Charles T. Munger (the “Fellowship Grant”). We may only issue these shares if the applicable eligibility, service and performance conditions under the Fellowship Grant are satisfied. The registration of the shares of our common stock covered by this prospectus supplement satisfies our contractual obligation to do so, but does not necessarily mean that all, or any, of these shares will be issued.

We will receive no cash proceeds from any issuance of the shares of our common stock covered by this prospectus supplement. Any such issuance will be made in satisfaction of amounts payable by our subsidiaries to the applicable operating partners and certain permitted designees pursuant to the Fellowship Grant and the applicable management agreements.

Our common stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “WELL.” On October 26, 2026, the last reported sale price of our common stock on the NYSE was $240.61 per share.

Investing in our common stock involves risk. Before making a decision to invest in our common stock, you should carefully consider each of the factors described or referred to under “Risk Factors” beginning on page S-2 of this prospectus supplement.

Neither the Securities and Exchange Commission nor any state or other securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is October 27, 2026.


	Page
PROSPECTUS SUPPLEMENT SUMMARY	S-1
RISK FACTORS	S-2
FORWARD-LOOKING STATEMENTS	S-4
USE OF PROCEEDS	S-6
DESCRIPTION OF CAPITAL STOCK AND RESTRICTIONS ON TRANSFER OF SECURITIES	S-7
PLAN OF DISTRIBUTION	S-11
LEGAL MATTERS	S-12
EXPERTS	S-12
WHERE YOU CAN FIND MORE INFORMATION	S-13
DOCUMENTS INCORPORATED BY REFERENCE	S-14


	Page
ABOUT THIS PROSPECTUS	1
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS	2
WHERE YOU CAN FIND ADDITIONAL INFORMATION	4
DOCUMENTS INCORPORATED BY REFERENCE	4
THE COMPANY	6
USE OF PROCEEDS	7
GENERAL DESCRIPTION OF THE OFFERED SECURITIES	8
DESCRIPTION OF DEBT SECURITIES	9
DESCRIPTION OF CAPITAL STOCK	17
DESCRIPTION OF DEPOSITARY SHARES	22
DESCRIPTION OF WARRANTS	26
DESCRIPTION OF UNITS	28
RESTRICTIONS ON TRANSFER OF SECURITIES	29
DESCRIPTION OF CERTAIN PROVISIONS OF CERTIFICATE OF INCORPORATION AND BY-LAWS OF WELLTOWER INC.	30
SELLING SECURITY HOLDERS	32
PLAN OF DISTRIBUTION	33
VALIDITY OF SECURITIES	38
EXPERTS	38